Lipella Pharmaceuticals Inc. is a privately held development-stage biotechnology company dedicated to improve patient care by developing novel products which focus on trans-mucosal therapy, delivering local treatments directly to their site of action. Lipella focuses on four therapeutic areas: urolo…
Lipella Pharmaceuticals Inc. is a privately held development-stage biotechnology company dedicated to improve patient care by developing novel products which focus on trans-mucosal therapy, delivering local treatments directly to their site of action. Lipella focuses on four therapeutic areas: urology, otorhinolaryngology, gastroenterology, and dermatology. In each of these areas, Lipella has liposomal therapies in various stages of development ranging from pre-clinical to early clinical in the U.S. and overseas.
Team (1)
Sectors Lipella Pharmaceuticals serves:
Life Sciences
Join Axial's Private M&A Platform
Lipella Pharmaceuticals connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
